[1]
Elsebaie, H., Yassa, W.S.M., Lasheen, S. and IbrahimIbrahim, N. 2021. Efficacy, Safety and Cost Effectiveness of Metronomic Low Dose Versus Intermittent High Dose Capecitabine in Metastatic Breast Cancer. Open Access Macedonian Journal of Medical Sciences. 9, B (Oct. 2021), 1048–1053. DOI:https://doi.org/10.3889/oamjms.2021.7089.